HI
NAVB

Hudock Inc’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Hudock Inc’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-250
Closed -$8K – 618
2015
Q1 		$8K Sell
250
-1,125
-82% -$38.1K ﹤0.01% 455
2014
Q4 		$52K Hold
1,375
– – 0.02% 202
2014
Q3 		$36K Sell
1,375
-150
-10% -$3.97K 0.02% 251
2014
Q2 		$45K Hold
1,525
– – 0.05% 230
2014
Q1 		$56K Hold
1,525
– – 0.05% 180
2013
Q4 		$63K Hold
1,525
– – 0.05% 159
2013
Q3 		$81K Hold
1,525
– – 0.08% 125
2013
Q2 		$81K Buy
+1,525
New +$76.1K 0.12% 125

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hudock Inc's NAVB Position: Q2 2015 in Review

Hudock Inc sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2015, closing a stake of 250 shares — an estimated $8K sold.

Hudock Inc first reported a position in NAVB in Q2 2013 and held it in 8 quarters. The position peaked at $81K in Q3 2013. 79 funds tracked by Wall St. Rank hold NAVB as of Q2 2015.

  • Hudock Inc reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Hudock Inc sold 250 Navidea Biopharmaceuticals Inc. shares in Q2 2015, an estimated $8K.
  • Hudock Inc first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 8 quarters.
  • Hudock Inc's Navidea Biopharmaceuticals Inc. position peaked at $81K in Q3 2013.
  • 79 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2015.

Based on Hudock Inc's 13F filing for Q2 2015, filed 13 Aug 2015.